Scpharmaceuticals INC Form 4 insider transactions

William Tober Abraham, a director of scPharmaceuticals Inc., acquired stock options for 19,750 shares at an exercise price of $4.11 on June 11, 2024.

Director Klaus R. Veitinger acquired 19,750 stock options in scPharmaceuticals Inc. on June 11, 2024.

Minnie Baylor-Henry, a director of scPharmaceuticals Inc., acquired stock options for 19,750 shares of common stock on June 11, 2024.

Director Sara Bonstein acquired 19,750 stock options in scPharmaceuticals Inc. on June 11, 2024.

scPharmaceuticals CEO John H. Tucker reports the vesting of options for 56,025 shares of common stock following the achievement of performance conditions.